Patent · US Active

RNA based biomaterial for tissue engineering applications

US10335498B2 · kind B2 · utility

1Cited by
0References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 29, 2015
Grant dateJul 2, 2019
Priority date
Expiry dateDec 29, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2430/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides compositions and methods useful for tissue engineering including a composition having chemically modified RNA (cmRNA) encapsulated in or complexed with a non-viral delivery vehicle and a biocompatible, bioresorbable scaffold and methods of using the composition to regenerate, for example, bone tissue.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.